MenC-CRM

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines

Conditions

HealthyMeningococcal Meningitis

Phase 2

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

CompletedNCT00310856

Novartis VaccinesMeningococcal Meningitis

Start: 2005-06-30End: 2006-11-30Updated: 2018-10-09

Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

CompletedNCT00381615

Novartis VaccinesHealthy

Start: 2006-09-30End: 2008-08-31Updated: 2015-10-09